Still Seeking New Growth Areas, Cephalon Reassures Investors It Can Continue To Build Nuvigil And Treanda

Cephalon highlighted the life-cycle management of its existing franchises during an R&D day held in New York on Nov. 18, with a focus on Nuvigil and Treanda.